C12N 15/866
Baculoviral vectors
C12N15/866 (Baculoviral vectors) appears on 13 US grants and 30 published applications in this corpus.
Search patents in C12N- Granted patents
- 13
- Published applications
- 30
- Assignees
- 24
- Inventors
- 92
- Latest grant
- 4 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2013 | 1 | 2 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 0 | 2 |
| 2018 | 0 | 2 |
| 2019 | 0 | 3 |
| 2020 | 0 | 3 |
| 2021 | 3 | 3 |
| 2022 | 1 | 2 |
| 2023 | 3 | 3 |
| 2024 | 0 | 5 |
| 2025 | 3 | 3 |
| 2026 | 2 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Baculovirus expression vector4 Aug 2026US 12,697,381 B2Intervet Inc.
- Baculovirus expression system28 Jul 2026US 12,692,481 B2Virovek, Inc.
- Expression cassette containing overlapping open reading frames and application16 Sep 2025US 12,416,019 B2Genevoyager (Wuhan) Co., Ltd.
- Vaccine to protect a pig against Actinobacillus pleuropneumoniae12 Aug 2025US 12,383,612 B2Intervet Inc.
- Recombinant bovine immunodeficiency virus-like particles comprising an influenza HA transmembrane domain and C-terminus20 May 2025US 12,303,560 B2Medigen, Inc.
- Pharmaceutical composition for resisting infection with sars-cov-2 or mutant thereof, and combined drug thereof12 Feb 2026US 2026/0041761 A1Westvac Biopharma Co., Ltd.
- Arthropod chemosensory receptors and uses thereof4 Dec 2025US 2025/0368699 A1
- Spodoptera frugiperda pupa ovary cell line with high baculovirus production, and construction and use thereof23 Oct 2025US 2025/0327024 A1Institute of Zoology, Chinese Academy of Sciences
- Expression cassette containing overlapping open reading frames and application6 Feb 2025US 2025/0043307 A1Genevoyager (Wuhan) Co., Ltd.
- Gene therapy construct for treating pompe disease, pharmaceutical composition, and method21 Nov 2024US 2024/0384297 A1Beijing Genecradle Pharmaceutical Co., Ltd.
Most cited
By later US patents
- Vectors expressing SARS immunogens, compositions containing such vectors or expression products thereof, methods and assays for making and using13US 8,541,003 B2Protein Sciences Corporation · 2013
- Compositions comprising recombinant bacillus cells and another biological control agent7US 11,406,107 B2Bayer CropScience AG · 2022
- Compositions and methods for fabricating synthetic dragline spider silk2US 10,981,959 B2Seevix Material Sciences Ltd. · 2021
- Recombinant bovine immunodeficiency virus gag virus-like particles containing influenza immunogens1US 11,576,965 B2Medigen, Inc. · 2023